AN ACT RELATING TO HEALTH AND SAFETY -- TERMINAL PATIENTS' RIGHT TO TRY ACT
Allows terminally ill Rhode Island patients legal access to unapproved experimental treatments when standard care fails, pending informed consent and medical eligibility.
Allows terminally ill Rhode Island patients legal access to unapproved experimental treatments when standard care fails, pending informed consent and medical eligibility.
HB 8329 establishes a "Right to Try" framework that would allow terminally ill patients in Rhode Island to access experimental medications and treatments that have not yet received full FDA approval. The bill creates a legal pathway for dying patients to attempt unapproved medical interventions when standard treatments have been exhausted, provided they meet specific eligibility criteria and receive informed consent.
This legislation addresses a fundamental tension in healthcare policy: the desire to protect patients from ineffective or dangerous treatments versus respecting individual autonomy at end-of-life. For terminally ill patients with no remaining standard options, access to experimental therapies may offer hope, though it also raises questions about false hope, exploitation, and the proper balance between caution and compassion in medical decision-making.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.